C Garrido-Colino1,6,7,8 A H Haro Diaz2, E J Bardón-Cancho1,6,7, M Navarro Gomez3,6,7, C Beléndez1,6,7,8, J Huerta Aragonés1,6,7, M Garcia-Morin1,6,7, C M Fernández-Llamazares5,6, A Burillo4,6, E Cela1,6,7,8
1Pediatric Hematology and Oncology Unit, Department of Pediatrics, Hospital General Universitario Gregorio Maranón, Madrid, Spain.
2 Department of Pediatrics, Hospital Universitario Torrejón de Ardoz, Madrid, Spain.
3 Pediatric Infectious Disease, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
4 Department of Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
5 Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
6 Universidad Complutense Madrid. UCM. Spain.
7 Instituto Investigación Biomedica Gregorio Marañón IiSGM.
8 Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, España.
Eduardo Jesús Bardón-Cancho.
Mail: edubc15@hotmail.com
None of the authors of this article have conflicts of interest to clarify. They have no commercial interests or other associations that could pose a conflict of interest.
Text word count: 3190
Abstract word count: 199
Brief running title: Antifungal prophilaxis with micafungin after bone marrow transplantation.
Key words: Antifungal prophylaxis, BMT for sickle cell disease, micafungin, children.
Tables: 2
Figures: 1